Voluntis
Aptar Digital Health is a global leader in end-to-end digital solutions that enhance patient experiences. They combine expertise with a diverse portfolio of products and platforms, including mobile and web applications, sensors, wearables, and connected drug delivery systems. Their mission is to make patient experiences better through holistic, patient-centric, and innovative digital interventions supporting chronic disease management across multiple indications.
Industries
Nr. of Employees
medium (51-250)
Voluntis
36-38 rue de la Princesse 78430 Louveciennes France
Products
Companion Apps
Patient-facing mobile and web applications providing onboarding, symptom tracking, adherence tools and communication channels with care teams.
Connected Drug Delivery Integrations
Connected device integrations that capture usage data from drug delivery systems and transmit it to digital platforms for monitoring and analytics.
Disease Management Platform
Platform to coordinate care, aggregate patient data across modalities and provide tools for longitudinal disease management and remote monitoring.
Digital Diagnostics (AI/ML and digital biomarkers)
AI/ML-driven diagnostic modules and digital biomarker workflows designed to support detection, monitoring and treatment planning.
Companion Apps
Patient-facing mobile and web applications providing onboarding, symptom tracking, adherence tools and communication channels with care teams.
Connected Drug Delivery Integrations
Connected device integrations that capture usage data from drug delivery systems and transmit it to digital platforms for monitoring and analytics.
Disease Management Platform
Platform to coordinate care, aggregate patient data across modalities and provide tools for longitudinal disease management and remote monitoring.
Digital Diagnostics (AI/ML and digital biomarkers)
AI/ML-driven diagnostic modules and digital biomarker workflows designed to support detection, monitoring and treatment planning.
Services
Clinical and post-marketing study support including digital data capture, RWE generation and virtual trial components.
Design and delivery of patient-facing programs including digital PSPs, onboarding, education and adherence support.
Human factors and UX services to ensure usability and regulatory alignment of digital health products.
Managed hosting, technical operations and global maintenance for digital platforms.
Quality system implementation and regulatory submission support for digital health products and diagnostic algorithms.
Evidence generation, payer engagement and medical affairs support to facilitate product adoption.
Clinical and post-marketing study support including digital data capture, RWE generation and virtual trial components.
Design and delivery of patient-facing programs including digital PSPs, onboarding, education and adherence support.
Human factors and UX services to ensure usability and regulatory alignment of digital health products.
Managed hosting, technical operations and global maintenance for digital platforms.
Quality system implementation and regulatory submission support for digital health products and diagnostic algorithms.
Evidence generation, payer engagement and medical affairs support to facilitate product adoption.
Expertise Areas
- Companion app development
- SaMD lifecycle and regulated software
- Connected device integration
- Digital diagnostics and AI/ML
Key Technologies
- Artificial intelligence / machine learning
- Digital biomarkers
- Mobile and web application platforms
- Wearable and sensor integration
News & Updates
Aptar Digital Health announced an enterprise agreement with Biogen to develop digital health solutions.
Aptar Digital Health announced the acquisition of Healint to strengthen its portfolio.
Partnership with SHL Medical to improve patient experience with self-injectable therapies.
Aptar Digital Health announced a licensing agreement with AstraZeneca for AI-powered screening algorithms.
Aptar Digital Health reported positive results of iPUMP® in allergen immunotherapy adherence.
Aptar Digital Health announced an enterprise agreement with Biogen to develop digital health solutions.
Aptar Digital Health announced the acquisition of Healint to strengthen its portfolio.
Partnership with SHL Medical to improve patient experience with self-injectable therapies.
Aptar Digital Health announced a licensing agreement with AstraZeneca for AI-powered screening algorithms.
Aptar Digital Health reported positive results of iPUMP® in allergen immunotherapy adherence.